Quarterly report pursuant to Section 13 or 15(d)

Detail of Certain Accounts (Tables)

v3.22.1
Detail of Certain Accounts (Tables)
 3 Months Ended
Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Cash and Cash Equivalents
Amounts related to Quanta’s cash and cash equivalents based on geographic location of the bank accounts were as follows (in thousands):
  March 31, 2022 December 31, 2021
Cash and cash equivalents held in domestic bank accounts $ 211,128  $ 205,781 
Cash and cash equivalents held in foreign bank accounts 27,130  23,316 
Total cash and cash equivalents $ 238,258  $ 229,097 
Amounts related to cash and cash equivalents held by joint ventures and the captive insurance company, which are included in Quanta’s total cash and cash equivalents balances, were as follows (in thousands):
  March 31, 2022 December 31, 2021
Cash and cash equivalents held by domestic joint ventures $ 17,309  $ 21,828 
Cash and cash equivalents held by foreign joint ventures 5,914  3,461 
Total cash and cash equivalents held by joint ventures 23,223  25,289 
Cash and cash equivalents held by captive insurance company 134,758  133,302 
Cash and cash equivalents not held by joint ventures or captive insurance company 80,277  70,506 
Total cash and cash equivalents $ 238,258  $ 229,097 
Accounts Payable and Accrued Expenses
Accounts payable and accrued expenses consisted of the following (in thousands):
  March 31, 2022 December 31, 2021
Accounts payable, trade $ 1,341,088  $ 1,251,118 
Accrued compensation and related expenses 442,264  547,161 
Other accrued expenses 535,037  456,392 
Accounts payable and accrued expenses $ 2,318,389  $ 2,254,671